Back to Peptides
Ovagen
Liver & Gastrointestinal HealthOvagen is a liver-specific peptide bioregulator derived from organ peptides and studied for hepatic regeneration, enzyme stabilization, and oxidative protection. It may aid in liver recovery following toxic damage, viral infection, or age-related liver decline.
Reconstitute
3 mL BAC + 5mg vial
17 mcg/unit
Daily Range
0.5–5 mcg Subcutaneous (SQ)
Daily
Standard Dose
2 mcg
Cycle
4–8 weeks
then reassess
Ovagenliver peptidehepatic regenerationdetox supportorgan-specific bioregulator
Dosing & Reconstitution Guide
Dosing should not exceed 300mcg daily in research settings. Monitor for hormonal changes during use. Effects on reproductive function have not been validated in human clinical trials.
Standard / Gradual Approach
standardPhaseDoseVolume
Week 150mcg
Week 2100mcg
Week 3150mcg
Week 4200mcg
Protocol Summary
Subcutaneous (SQ): Daily · Dose range 0.5–5 mcg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
Administer daily for 20–30 days. Repeat every 4–6 months based on liver status and metabolic demand.
🧪 Quick Start
BAC Water
3 mL
Potential Benefits & Use Cases
Ovagen is not approved for human use and should only be used for preclinical research purposes.
Supports gastrointestinal and hepatic tissue bioregulation (preclinical)
Demonstrates 18-fold increase in liver cell regeneration markers, more pronounced in elderly models (preclinical)
Exhibits cytoprotective effects via modulation of aging-related gene expression (in vitro)
Rapid metabolism and low immunogenicity characteristic of ultrashort peptides (preclinical)
Clinical data Strong preclinical Limited data
Mechanism of Action
→Normalizes gene expression in liver cells
→Promotes DNA repair and protein synthesis in hepatocytes
→Stabilizes liver enzyme regulation and bile metabolism
→Enhances glutathione activity and antioxidant defense in hepatic tissue
Lifestyle & Optimization
timing
Consistent daily dosing.
diet
Antioxidant-rich diet to support ovarian/liver health.
exercise
Exercise moderately 3–4 times weekly.
sleep
Adequate sleep (7–9 hours). Manage stress through mindfulness practices.
Peptide Research & Preclinical Studies
Evidence-Based Research Findings
Study TitleType
Side Effects & Safety
Common Side Effects
• Mild digestive discomfort, occasional (user-reported)
Long-Term Safety Data
• No controlled human trials exist
🧮 Dose Calculator
Concentration
16.7
mcg/unit
Draw Volume
30
units (0.300 mL)
For a 500 mcg dose, draw 30 units on a U-100 insulin syringe
🧬
Bioavailability & Absorption
SubQ Injection
High tissue penetration via subcutaneous route for liver targeting
Oral Administration
Not suitable due to proteolytic breakdown
Half-Life
Estimated 3–4 hours
Degradation
Cleared via hepatic and renal pathways
Tissue Specificity
Targets liver parenchyma and hepatic immune cells
⚗️
Peptide Details
Molecular Weight
1520.76
Formula
C60H98N18O22S
Sequence
GEPPPGKPADDAGLG
⚖️
Legal Status & Regulatory
RegionStatus
FDANot Approved
EUNot Approved
AustraliaNot Approved
CanadaNot Approved
Storage Instructions
Lyophilized (Powder)
Store lyophilized powder at 2-8°C
Reconstituted (Mixed)
After reconstitution, maintain at 2-8°C and use within 21 days. Protect from light exposure.